Recapitulating long-QT syndrome using induced pluripotent stem cell technology
Ralf J Dirschinger1, Alexander Goedel, Alessandra Moretti
1Medizinische Klinik-Kardiologie, Klinikum rechts der Isar-Technische Universität München, Ismaninger Straße 22, 81675, München, Germany.
Pediatric Cardiology
|March 14, 2012
Summary
Patient-specific induced pluripotent stem cells (iPSC) create advanced in vitro disease models. These models help study hereditary disorders and test new cardiovascular drugs for personalized medicine.
Area of Science:
- Biotechnology
- Stem Cell Biology
- Cardiovascular Research
Background:
- Induced pluripotent stem cells (iPSC) offer a novel approach for creating patient-specific in vitro disease models.
- Reprogramming somatic cells into iPSC allows for the generation of patient-derived cells for research.
- These patient-specific iPSC can be differentiated into various cell types, including cardiomyocytes.
Purpose of the Study:
- To explore the utility of patient-specific iPSC in modeling hereditary cardiovascular disorders.
- To demonstrate the recapitulation of disease pathophysiology in iPSC-derived cells.
- To highlight the potential of iPSC-based platforms for drug testing and personalized medicine.
Main Methods:
- Generation of patient-specific induced pluripotent stem cells (iPSC) from somatic cells of individuals with hereditary disorders.
- Differentiation of iPSC into relevant somatic cell types, such as cardiomyocytes.
- In vitro analysis of iPSC-derived cells to assess disease-specific features and cellular pathophysiology.
Main Results:
- Successful modeling of different types of long-QT syndrome using patient-specific iPSC-derived cardiomyocytes.
- Demonstration that iPSC-derived cardiomyocytes recapitulated key in vitro features of the modeled diseases.
- Validation of iPSC technology for studying cellular mechanisms of hereditary cardiovascular conditions.
Conclusions:
- Patient-specific iPSC technology provides a powerful tool for in vitro modeling of monogenetic and polygenetic cardiovascular disorders.
- iPSC-derived disease models enable detailed cellular-level studies of pathophysiology.
- iPSC platforms hold significant promise for preclinical drug screening, assessment of drug side effects (e.g., QT-interval prolongation), and the development of tailored patient therapies.
Related Concept Videos
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...